Cargando…

How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma

SIMPLE SUMMARY: Despite improvements in the early identification and successful control of primary uveal melanoma, 50% of patients will develop metastatic disease with only marginal improvements in survival. This review focuses on the tumor microenvironment and the cross-talk between tumor and immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marseglia, Mariarosaria, Amaro, Adriana, Solari, Nicola, Gangemi, Rosaria, Croce, Elena, Tanda, Enrica Teresa, Spagnolo, Francesco, Filaci, Gilberto, Pfeffer, Ulrich, Croce, Michela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122936/ https://www.ncbi.nlm.nih.gov/pubmed/33922591 http://dx.doi.org/10.3390/cancers13092043

Ejemplares similares

Cerivastatin Synergizes with Trametinib and Enhances Its Efficacy in the Therapy of Uveal Melanoma
por: Amaro, Adriana Agnese, et al.
Publicado: (2023)

Uveal Melanoma Metastasis
por: Rossi, Ernesto, et al.
Publicado: (2021)

Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives
por: Croce, Michela, et al.
Publicado: (2019)

Interdependence of Molecular Lesions That Drive Uveal Melanoma Metastasis
por: Reggiani, Francesco, et al.
Publicado: (2023)

Potential Onco-Suppressive Role of miR122 and miR144 in Uveal Melanoma through ADAM10 and C-Met Inhibition
por: Amaro, Adriana, et al.
Publicado: (2020)

The biology of uveal melanoma
por: Amaro, Adriana, et al.
Publicado: (2017)

Data Fusion Techniques for the Integration of Multi-Domain Genomic Data from Uveal Melanoma
por: Pfeffer, Max, et al.
Publicado: (2019)

Secondary Somatic Mutations in G-Protein-Related Pathways and Mutation Signatures in Uveal Melanoma
por: Piaggio, Francesca, et al.
Publicado: (2019)

Uveal Melanoma
por: Pfeffer, Ulrich
Publicado: (2019)

Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?
por: Tanda, Enrica Teresa, et al.
Publicado: (2021)

Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
por: Genova, Carlo, et al.
Publicado: (2022)

Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells
por: Amaro, Adriana, et al.
Publicado: (2023)

Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting
por: Vanni, Irene, et al.
Publicado: (2023)

Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma
por: Boutros, Andrea, et al.
Publicado: (2021)

Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma
por: Pastorino, Lorenza, et al.
Publicado: (2022)

Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale?
por: Tanda, Enrica Teresa, et al.
Publicado: (2021)

Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression
por: Gangemi, Rosaria, et al.
Publicado: (2012)

Immunotherapies for the Treatment of Uveal Melanoma—History and Future
por: Schank, Timo E., et al.
Publicado: (2019)

Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?
por: Castet, Florian, et al.
Publicado: (2019)

Recent Advances and Challenges in Uveal Melanoma Immunotherapy
por: Fu, Yihang, et al.
Publicado: (2022)

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
por: Mignard, Claire, et al.
Publicado: (2018)

Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?
por: Rossi, Ernesto, et al.
Publicado: (2019)

Treatment beyond progression with anti-PD-1/PD-L1 based regimens in advanced solid tumors: a systematic review
por: Spagnolo, Francesco, et al.
Publicado: (2021)

A Rare Case of Metastatic Uveal Melanoma Responding to Immunotherapy
por: Fadel, Celine A, et al.
Publicado: (2022)

Uveal Melanoma
por: Papastefanou, Vasilios P., et al.
Publicado: (2011)

Current status and perspectives in immunotherapy for metastatic melanoma
por: Marconcini, Riccardo, et al.
Publicado: (2018)

Radiotherapy may augment response to immunotherapy in metastatic uveal melanoma patients
por: Grynberg, Shirly, et al.
Publicado: (2022)

New Insights into Molecular Oncogenesis and Therapy of Uveal Melanoma
por: Violanti, Sara Silvia, et al.
Publicado: (2019)

Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review
por: Spagnolo, Francesco, et al.
Publicado: (2021)

MRI of Uveal Melanoma
por: Ferreira, Teresa A., et al.
Publicado: (2019)

Differential Expression of DNA Repair Genes in Prognostically-Favorable versus Unfavorable Uveal Melanoma
por: Dogrusöz, Mehmet, et al.
Publicado: (2019)

Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines
por: Nencetti, Susanna, et al.
Publicado: (2020)

Anti-Cancer Immunotherapies Targeting Telomerase
por: Negrini, Simone, et al.
Publicado: (2020)

A Rare Thyroid Metastasis from Uveal Melanoma and Response to Immunotherapy Agents
por: Collins, Dearbhaile Catherine, et al.
Publicado: (2016)

IL-27 Mediates PD-L1 Expression and Release by Human Mesothelioma Cells
por: Carbotti, Grazia, et al.
Publicado: (2021)

Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma
por: Dono, M, et al.
Publicado: (2014)

Gamma knife radiosurgery for the treatment of uveal melanoma and uveal metastases
por: Reynolds, Margaret M., et al.
Publicado: (2017)

Evaluation and Comparison of Multi-Omics Data Integration Methods for Subtyping of Cutaneous Melanoma
por: Amaro, Adriana, et al.
Publicado: (2022)

Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy
por: Qin, Yong, et al.
Publicado: (2020)

Exoresection and Endoresection for Uveal Melanoma
por: Gündüz, Kaan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8842jihvvdqun5bhmja30t5uds